Communiqués Standard BioTools Inc.

Actions

LAB

US34385P1084

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 05/10/2026			Varia. 5j.	Varia. 1 janv.
0,7630 ^USD	+2,46%		+4,91%	-40,39%

30/09	Multiplex Bio Inc. a annulé l’acquisition de l’activité de cytométrie de masse de Standard BioTools Inc. (NasdaqGS:LAB).	CI
05/08	Standard BioTools Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

05/10	Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED	AQ
30/09	Standard BioTools Provides Update on Sale of Mass Cytometry Business	AQ
05/08	Standard BioTools: Q2 Earnings Snapshot	AQ
05/08	Standard BioTools Reports Second Quarter 2026 Financial Results	AQ
29/07	Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences	AQ
28/07	Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences	AQ
22/07	Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026	AQ
20/07	Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction	AQ
08/06	Standard BioTools and Treeline Biosciences Announce Merger Agreement	AQ
05/05	Standard BioTools: Q1 Earnings Snapshot	AQ
05/05	Standard BioTools Reports First Quarter 2026 Financial Results	AQ
21/04	Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026	AQ
24/02	Standard BioTools: Q4 Earnings Snapshot	AQ
24/02	Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
10/02	Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026	AQ
08/01	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue	AQ
19/11	Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry	BU
10/11	Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks	PR
04/11	Standard BioTools: Q3 Earnings Snapshot	AQ
04/11	Standard BioTools Reports Third Quarter 2025 Financial Results	AQ
21/10/25	Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025	AQ
03/09/25	Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development	PR
03/09/25	Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development	AQ
12/08/25	Standard BioTools: Q2 Earnings Snapshot	AQ
11/08/25	Standard BioTools Reports Second Quarter 2025 Financial Results	AQ